OA
CVS icon

Oxbow Advisors’s CVS Health CVS Stock Holding History

Oxbow Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,945
Closed -$717K – 297
2018
Q4 		$717K Sell
10,945
-1,520
-12% -$113K 0.1% 165
2018
Q3 		$981K Sell
12,465
-135
-1% -$9.65K 0.12% 147
2018
Q2 		$811K Sell
12,600
-310
-2% -$20.4K 0.1% 160
2018
Q1 		$803K Buy
12,910
+135
+1% +$9.69K 0.16% 124
2017
Q4 		$926K Hold
12,775
– – 0.17% 132
2017
Q3 		$1.04M Buy
12,775
+685
+6% +$54.2K 0.2% 123
2017
Q2 		$973K Hold
12,090
– – 0.17% 132
2017
Q1 		$949K Buy
12,090
+90
+0.8% +$7.18K 0.15% 137
2016
Q4 		$947K Buy
+12,000
New +$971K 0.12% 145

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxbow Advisors's CVS Position: Q1 2019 in Review

Oxbow Advisors sold out of CVS Health (CVS) in Q1 2019, closing a stake of 10,945 shares — an estimated $717K sold.

Oxbow Advisors first reported a position in CVS in Q4 2016 and held it in 9 quarters. The position peaked at $1.04M in Q3 2017. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • Oxbow Advisors reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
  • Oxbow Advisors sold 10,945 CVS Health shares in Q1 2019, an estimated $717K.
  • Oxbow Advisors first reported a position in CVS Health in Q4 2016 and held it in 9 quarters.
  • Oxbow Advisors's CVS Health position peaked at $1.04M in Q3 2017.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Oxbow Advisors's 13F filing for Q1 2019, filed 1 May 2019.